West Pharmaceutical Services Inc (WST)
319.10
-1.78
(-0.55%)
USD |
NYSE |
Nov 22, 15:06
West Pharmaceutical Services Total Liabilities (Quarterly): 923.00M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 923.00M |
| June 30, 2024 | 912.60M |
| March 31, 2024 | 921.70M |
| December 31, 2023 | 948.50M |
| September 30, 2023 | 886.50M |
| June 30, 2023 | 922.90M |
| March 31, 2023 | 947.40M |
| December 31, 2022 | 931.90M |
| September 30, 2022 | 846.00M |
| June 30, 2022 | 937.30M |
| March 31, 2022 | 968.50M |
| December 31, 2021 | 978.40M |
| September 30, 2021 | 940.30M |
| June 30, 2021 | 900.90M |
| March 31, 2021 | 910.70M |
| December 31, 2020 | 939.30M |
| September 30, 2020 | 863.90M |
| June 30, 2020 | 786.00M |
| March 31, 2020 | 756.30M |
| December 31, 2019 | 768.20M |
| September 30, 2019 | 686.40M |
| June 30, 2019 | 678.10M |
| March 31, 2019 | 666.70M |
| December 31, 2018 | 582.60M |
| September 30, 2018 | 594.30M |
| Date | Value |
|---|---|
| June 30, 2018 | 591.80M |
| March 31, 2018 | 564.30M |
| December 31, 2017 | 582.90M |
| September 30, 2017 | 613.50M |
| June 30, 2017 | 600.60M |
| March 31, 2017 | 564.90M |
| December 31, 2016 | 599.20M |
| September 30, 2016 | 593.00M |
| June 30, 2016 | 595.70M |
| March 31, 2016 | 594.20M |
| December 31, 2015 | 671.20M |
| September 30, 2015 | 671.20M |
| June 30, 2015 | 674.30M |
| March 31, 2015 | 654.90M |
| December 31, 2014 | 712.80M |
| September 30, 2014 | 703.20M |
| June 30, 2014 | 732.10M |
| March 31, 2014 | 773.60M |
| December 31, 2013 | 765.20M |
| September 30, 2013 | 827.80M |
| June 30, 2013 | 828.50M |
| March 31, 2013 | 831.20M |
| December 31, 2012 | 835.10M |
| September 30, 2012 | 810.30M |
| June 30, 2012 | 783.30M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
756.30M
Minimum
Mar 2020
978.40M
Maximum
Dec 2021
899.52M
Average
922.30M
Median
Total Liabilities (Quarterly) Benchmarks
| Repligen Corp | 813.96M |
| Perspective Therapeutics Inc | 62.68M |
| Retractable Technologies Inc | 74.35M |
| Xtant Medical Holdings Inc | 53.16M |
| Catheter Precision Inc | 13.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.675B |
| Shareholders Equity (Quarterly) | 2.752B |
| Debt to Equity Ratio | 0.0736 |
| Current Ratio | 3.002 |
| Net Debt Paydown Yield | 0.00% |